Classifi integrates multispecialty scientific expertise with technology to scale the delivery of high-quality genetic test results. The session will demonstrate how the integration of these components impacts test accuracy now and in the future, with a focus on hereditary gastrointestinal cancer conditions.
Presented by:
Holly LaDuca, MS, CGC, Clinical Strategy Manager, Ambry Genetics
Jeni Herrera-Mullar, MGC, LCGC, DMA, Principal Clinical Scientist, Ambry Genetics
Tina Pesaran, MA, MS, CGC, Vice President, Genomic Science, Ambry Genetics